> Home > 2011 News Releases > Nov. 8 Scottsdale event to explore breakthroughs in cancer treatment

Nov. 8 Scottsdale event to explore breakthroughs in cancer treatment



  Oct. 27, 2011

  Contact:  Janet Secor, assistant to the mayor, (480) 312-7977

  Nov. 8 Scottsdale event to explore breakthroughs
  in cancer treatment

 

A special Mayor and City Council breakfast in Scottsdale Nov. 8 will feature a panel of local experts whose work treating and diagnosing cancer is making international headlines.

The free event, “Scottsdale’s World-Class Cancer Care & Research,” will begin at 7:30 a.m. Tuesday, Nov. 8 at the Virginia G. Piper Cancer Center at Scottsdale Healthcare (10460 N. 92nd St.). It is open to the public and includes a complimentary continental breakfast.

Those attending will hear about the collaborative cancer treatment and research conducted at the Virginia G. Piper Cancer Center at Scottsdale Healthcare, the Translational Genomics Research Institute (TGen) and Mayo Clinic Scottsdale, all of which are located along a five-mile stretch of Shea Boulevard.

The keynote speaker will be world-renowned oncologist Daniel Von Hoff, M.D., chief scientific officer for Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare. He is expected to discuss the breakthrough cancer research taking place at the Virginia G. Piper Cancer Center at Scottsdale Healthcare, and the collaborations among researchers that make Scottsdale a destination for cancer care.

Dr. Von Hoff, who also is physician-in-chief at TGen and professor of medicine, Mayo Clinic, is leading an international research study of a promising new treatment for pancreatic cancer, especially meaningful given that November is National Pancreatic Cancer Awareness Month.

Following Dr. Von Hoff’s keynote will be a panel discussion on “What the Future Holds for Collaborations and Cancer Research in Scottsdale” featuring: Mark Slater, PhD, vice president, Scottsdale Healthcare Research Institute; Stephen Gately, Ph.D., president & chief scientific officer, TGen; Keith Stewart, M.B., ChB, dean of research, Mayo Clinic in Arizona and Rafael Fonseca, M.D., deputy director, Mayo Clinic Cancer Center. 

 

About the Virginia G. Piper Cancer Center at Scottsdale Healthcare

The nonprofit Virginia G. Piper Cancer Center at Scottsdale Healthcare is the Valley’s premiere hospital-based cancer treatment and research center. Its research has been featured in The New England Journal of Medicine, Journal of Clinical Oncology and many other medical journals. As a primary clinical research site for TGen, it has achieved breakthroughs in pancreatic, basal cell, lung and other cancer treatments. Physicians from across the U.S. and beyond refer patients to the Virginia G. Piper Cancer Center, who travel to Scottsdale for their treatment. The Virginia G. Piper Cancer Center at Scottsdale Healthcare is located at 10460 N. 92nd St. on the campus of Scottsdale Healthcare Shea Medical Center. For more information, visit www.shc.org/cancer.

 

About the Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit MayoClinic.com or MayoClinic.org/news.

 

About TGen

The Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. TGen is affiliated with the Van Andel Research Institute in Grand Rapids, Michigan. For more information, visit: www.tgen.org.

 

Related Links

Other Links